Brief: Jasper Therapeutics Reports Fiscal 2022 Financial Results

Jasper Therapeutics

08/03/2023 21:10

March 8 (Reuters) - Jasper Therapeutics Inc  JSPR.O :
    * JASPER THERAPEUTICS REPORTS FISCAL 2022 FINANCIAL RESULTS
AND
PROVIDES A BUSINESS UPDATE
    * : QTRLY LOSS PER SHARE  $0.36
    * Q4 EARNINGS PER SHARE VIEW $-0.36 -- REFINITIV IBES DATA
    * : CASH AND CASH EQUIVALENTS AS OF DECEMBER 31, 2022 WERE
$38.3
MILLION

Source text for Eikon:  ID:nGNX3ZNwlP 
Further company coverage:  JSPR.O 

 ((Reuters.Briefs@thomsonreuters.com;))